Multiple endocrine neoplasia type 1: duodenopancreatic tumors

Area of Science:

• Endocrinology
• Oncology
• Gastroenterology

Background:

• Duodenopancreatic endocrine tumors are a frequent and lethal component of Multiple Endocrine Neoplasia type 1 (MEN-1).
• Patient management is challenging due to the tumors' variable hormonal activity and unpredictable clinical course, ranging from indolent to fatal.
• A comprehensive understanding of these tumors is crucial for effective patient care.

Purpose of the Study:

• To review the current diagnostic methods for duodenopancreatic endocrine tumors in MEN-1 patients.
• To outline contemporary surveillance protocols for early detection and monitoring.
• To discuss established and emerging management strategies for these neoplasms.

Main Methods:

• Literature review of diagnostic modalities.
• Analysis of current surveillance guidelines.
• Synthesis of therapeutic approaches for MEN-1 related tumors.

Main Results:

• Diagnosis relies on a combination of imaging, biochemical testing, and histopathology.
• Surveillance protocols aim for early detection of tumor development and progression.
• Management strategies are tailored to tumor type, hormonal activity, and disease stage.

Conclusions:

• Effective management of duodenopancreatic endocrine tumors in MEN-1 requires a multidisciplinary approach.
• Timely diagnosis and vigilant surveillance are key to improving patient outcomes.
• Personalized treatment strategies are essential for addressing the complexities of these tumors.